Medicare Enrolled
Dr. Philip Rabito, M.D.
Optician · New York, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rabito from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rabito?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rabito
Dr. Philip Rabito is an optician specialist in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rabito performed 4,311 Medicare services across 1,237 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rabito received a total of $709,093 from 62 pharmaceutical and/or device companies across 1600 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rabito is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in NY
$709,093 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,311
Medicare services
Top 18% in NY for optician
1,237
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~216 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
1,546 | $4 | $88 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
927 | $80 | $456 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
623 | $106 | $379 |
| Obesity behavioral counseling, 15 minutes A 15-minute face-to-face session focused on behavioral counseling to help manage obesity. |
268 | $29 | $66 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
165 | $114 | $315 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
141 | $103 | $619 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
129 | $136 | $500 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
107 | $30 | $150 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
89 | $75 | $547 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
87 | $112 | $561 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
80 | $99 | $535 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
41 | $154 | $563 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
40 | $150 | $950 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
38 | $226 | $1,500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $143 | $758 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $52 | $330 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$709,093
Total received (2018-2024)
Avg $101,299/year across 7 years
Top 1% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
62
Companies
1,600
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$664,792 (93.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,736 (3.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$20,565 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$105,152
2023
$139,338
2022
$171,864
2021
$82,724
2020
$70,777
2019
$71,235
2018
$68,004
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Xeris Pharmaceuticals, Inc.
$60,675
Intra-Sana Laboratories
$18,326
Corcept Therapeutics
$16,744
CeQur Corporation
$4,415
Novo Nordisk Inc
$1,146
ABBVIE INC.
$569
Mannkind Corporation
$467
PFIZER INC.
$341
Boehringer Ingelheim Pharmaceuticals, Inc.
$340
Lilly USA, LLC
$284
Nevro Corp.
$280
SANOFI-AVENTIS U.S. LLC
$228
Amgen Inc.
$221
Amneal Pharmaceuticals LLC
$194
HEARTFLOW, INC.
$174
Astellas Pharma US Inc
$121
Esperion Therapeutics, Inc.
$110
Bayer Healthcare Pharmaceuticals Inc.
$95
Novartis Pharmaceuticals Corporation
$81
Kyowa Kirin, Inc.
$72
Antares Pharma, Inc.
$67
RECORDATI_RARE_DISEASES_INC.
$52
Merck Sharp & Dohme LLC
$45
Verity Pharmaceuticals Inc.
$44
IBSA Pharma Inc.
$22
Medtronic, Inc.
$22
Tolmar, Inc.
$16
Top 3 companies account for 91.1% of 2024 payments
All-time payments by company (2018-2024) ›
Corcept Therapeutics
$136,218
Janssen Pharmaceuticals, Inc
$133,229
Xeris Pharmaceuticals, Inc.
$74,233
Intuity Medical Inc
$70,353
Amryt Pharma Holdings Ltd
$64,512
Merck Sharp & Dohme Corporation
$50,046
Novo Nordisk Inc
$42,253
Zealand Pharma US, Inc.
$31,853
Intra-Sana Laboratories
$30,398
CeQur Corporation
$19,699
MannKind Corporation
$9,212
AbbVie Inc.
$9,011
Medtronic MiniMed, Inc.
$4,412
RECORDATI_RARE_DISEASES_INC.
$3,570
Chiasma, Inc.
$3,118
AbbVie, Inc.
$3,021
Mannkind Corporation
$2,657
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,654
VistaPharm, Inc.
$2,280
Amgen Inc.
$1,937
Lilly USA, LLC
$1,510
PFIZER INC.
$1,371
IBSA Pharma Inc.
$1,367
Nevro Corp.
$1,051
ABBVIE INC.
$1,035
SANOFI-AVENTIS U.S. LLC
$928
Abbott Laboratories
$752
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$555
Esperion Therapeutics, Inc.
$474
Amneal Pharmaceuticals LLC
$472
AstraZeneca Pharmaceuticals LP
$469
Biohaven Pharmaceutical Holding Company Ltd.
$429
EUSA Pharma (US) LLC
$331
Bayer HealthCare Pharmaceuticals Inc.
$320
Neurocrine Biosciences, Inc.
$300
Ascendis Pharma Inc
$297
Antares Pharma, Inc.
$264
Bayer Healthcare Pharmaceuticals Inc.
$225
Ipsen Biopharmaceuticals, Inc
$206
Medtronic, Inc.
$187
Currax Pharmaceuticals LLC
$184
HEARTFLOW, INC.
$174
Novartis Pharmaceuticals Corporation
$164
Horizon Therapeutics plc
$158
Biohaven Pharmaceuticals, Inc.
$150
Astellas Pharma US Inc
$138
Gilead Sciences, Inc.
$125
Aytu BioScience, Inc
$124
Kyowa Kirin, Inc.
$123
Janssen Scientific Affairs, LLC
$117
Shire North American Group Inc
$90
Merck Sharp & Dohme LLC
$66
Acerus Pharmaceuticals Corporation
$52
Verity Pharmaceuticals Inc.
$44
Orexigen Therapeutics, Inc.
$43
GLYCOMARK, INC.
$27
GRT US Holding, Inc.
$22
Supernus Pharmaceuticals, Inc.
$20
Althera Pharmaceuticals LLC
$19
Aytu Bioscience, Inc
$18
Tolmar, Inc.
$16
VIVUS LLC
$15
Top 3 companies account for 48.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Aimovig · BAQSIMI · BASAGLAR · BREZTRI · CHANTIX · COMIRNATY · CONTRAVE · CREON · CYCLOSET · CeQur Simplicity · Corlanor · Crysvita · DUEXIS · EVENITY · Epclusa · FARXIGA · FFRct · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre Pro · GATTEX · GVOKE HYPOPEN · GVOKE PFS · Glycomark · INTELLIS ADAPTIVESTIM · INVOKANA · ISTURISA · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LICART · LINZESS · LOKELMA · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · Minimed 530G · NATPARA · NEXLETOL · NEXLIZET · NOCDURNA · NURTEC ODT · Natesto · Omnia · Ozempic · PRADAXA · PRALUENT · PROCLAIM · Pogo Automatic Blood Glucose Monitoring System · Proclaim Family of SCS IPGs · Prolia · QSYMIA · QULIPTA · Qutenza · RAYOS · RECORLEV · RELTONE 200 MG · Repatha · Reveal LINQ · Roszet · Rybelsus · SIGNIFOR LAR · SKYTROFA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STEGLUJAN · SYNTHROID · Saxenda · Senza · Senza Spinal Cord Stimulation System · Sogroya · Somatuline Depot · Sylvant · Synthroid · TEPEZZA · TLANDO · TOUJEO · TRULICITY · TZIELD · Thyquidity · Tirosint · Tlando · UBRELVY · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VERQUVO · VIBERZI · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · ZEGALOGUE · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for optician in NY.
Geographic Context
Opticians within 10 mi
16,059
Per 100K population
986.6
County median income
$104,553
Nearest hospital
LENOX HILL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rabito is a clinical cardiology specialist, with above-average Medicare volume (top 18% in NY), with speaking/promotional industry engagement in the top 1% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rabito experienced with allergy skin test?
Based on Medicare claims data, Dr. Rabito performed 1,546 allergy skin test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rabito receive payments from pharmaceutical companies?
Yes. Dr. Rabito received a total of $709,093 from 62 companies across 1,600 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rabito's costs compare to other opticians in New York?
Dr. Rabito's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rabito) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in New York
Browse opticians in New York ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NY
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NY
Which NY opticians receive the most from drug and device companies.
By company
Corcept Therapeutics Payments to Doctors
See all physicians who received payments from Corcept Therapeutics.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Xeris Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Xeris Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology